Literature DB >> 15494528

The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling.

Shalini Pereira1, Hong Zhang, Toshiyuki Takai, Clifford A Lowell.   

Abstract

The Ig-like receptor family member, PIR-B, has been shown to play an inhibitory role in receptor signaling within B cells, mast cells, and dendritic cells. As it has been implicated in integrin-mediated responses, we investigated the effect of loss of the PIR-B protein on integrin-mediated signaling in primary murine myeloid cells. The pir-b-/- neutrophils displayed enhanced respiratory burst, secondary granule release, and a hyperadhesive phenotype when plated on surfaces coated with either extracellular matrix proteins or cellular adhesion molecules in the presence or absence of the soluble inflammatory agonist TNF-alpha. The pir-b-/- and wild-type cells responded equivalently when stimulated with TNF-alpha in suspension, indicating that the hyperresponsive phenotype of the pir-b-/- cells during adhesion was due to enhanced integrin signaling. Both wild-type and pir-b-/- neutrophils expressed similar levels of integrin subunits. Primary bone marrow-derived macrophages from pir-b-/- mice were also hyperadhesive and spread more rapidly than wild-type cells following plating on surfaces that cross-linked cellular beta2 integrins. Biochemical analysis of macrophages from pir-b-/- mice revealed enhanced phosphorylation and activation of proteins involved in integrin signaling. These observations point to a nonredundant role for PIR-B in the regulation of leukocyte integrin signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494528     DOI: 10.4049/jimmunol.173.9.5757

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism.

Authors:  Niraj R Mehta; Thien Nguyen; John W Bullen; John W Griffin; Ronald L Schnaar
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

Review 2.  LILRB receptor-mediated regulation of myeloid cell maturation and function.

Authors:  William van der Touw; Hui-Ming Chen; Ping-Ying Pan; Shu-Hsia Chen
Journal:  Cancer Immunol Immunother       Date:  2017-06-21       Impact factor: 6.968

Review 3.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

4.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 5.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

Review 6.  Paired immunoglobulin-like receptors and their MHC class I recognition.

Authors:  Toshiyuki Takai
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

7.  The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.

Authors:  Hyun-Ju Kim; Kaihua Zhang; Lihong Zhang; F Patrick Ross; Steven L Teitelbaum; Roberta Faccio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 8.  Role of PIR-B in autoimmune glomerulonephritis.

Authors:  Toshiyuki Takai; Akira Nakamura; Shota Endo
Journal:  J Biomed Biotechnol       Date:  2010-10-04

9.  Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease.

Authors:  Mercedes Gonzalez-Juarrero; Luke C Kingry; Diane J Ordway; Marcela Henao-Tamayo; Marisa Harton; Randall J Basaraba; William H Hanneman; Ian M Orme; Richard A Slayden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

10.  PIR-B-deficient mice are susceptible to Salmonella infection.

Authors:  Ikuko Torii; Satoshi Oka; Muneki Hotomi; William H Benjamin; Toshiyuki Takai; John F Kearney; David E Briles; Hiromi Kubagawa
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.